Tirzepatide tr factory purity 99%
TDS 12 Inquiries
72957-37-0
Research Grade
99.9%
Ningbo
111
5mg , 10mg , 15mg , 20mg or 30mg per vial,10vials/kit
2026-07-12
peptide
-
Product Description
-
Seller Information
-
Inquiry History
-
DescriptionGly-His-Lys is a tripeptide present at ~200ng/ml in association with α-globulin and albumin, in human blood plasma.CertificatesBasic Info
-
Product Name:
Tripeptide-1
Other Name:H-GLY-HIS-LYS-OH ACETATE SALT;H-GLY-HIS-LYS-OH ACOH;GLY-HIS-LYS ACETATE;GLY-HIS-LYS ACETATE SALT;GLY-HIS-LYS ACOH H2O;GLYCYL-L-HISTIDYL-L-LYSINE ACETATE;LIVER CELL GROWTH FACTOR;LIVER CELL GROWTH FACTOR ACETATE SALT
CAS No.:72957-37-0
Molecular Formula:C16H28N6O6
InChIKeys:MGNUTAFMLGJBGV-ACMTZBLWSA-N
Molecular Weight:400.44
EC Number:277-125-4
Color/Form:white
Categories:
Characteristics-
Water Solubility:
H2O: soluble 0.5mg/mL, clear, colorless
Critical Temperature & Pressure:-20°C
Research-
Class:
Dual agonist — GIPR, GLP-1R
Status:FDA-approved (Mounjaro / Zepbound)
Mechanism:Dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist. A 39-amino-acid modified peptide with a C20 fatty diacid moiety that enables albumin binding for extended half-life (~5 days). Selectively activates both GIPR and GLP-1R signaling pathways.
EC50 (Human GLP1R):0.934 nM
EC50 (Human GIPR):0.0224 nM
Source:Frias JP, et al. N Engl J Med. 2021;385(6):503-515.DOI
Clinical Development:NCT03954834; NCT03987919; NCT03882970; NCT03730662; NCT04039503
FDA:Mounjaro, Zepbound (approved 2022-05-13)
References-
ChEMBL:DrugBank:KEGG DRUG:PubChem:Disclaimer:
Tirzepatide is approved as a prescription medicine (Mounjaro, Zepbound) in certain jurisdictions. This listing is for industrial and laboratory research use only. Research-chemical listings on B2B marketplaces are not interchangeable with approved medicines. Confirm CAS, specification, and regulatory pathway with the seller. It is not medical advice, a clinical recommendation, or an approved therapy description.
Hazard IdentificationClassification of the substance or mixture
no data available
GHS label elements, including precautionary statements
Pictogram(s) no data available Signal word no data available
Hazard statement(s) no data available
Precautionary statement(s) Prevention no data available
Response no data available
Storage no data available
Disposal no data available
Other hazards which do not result in classification
no data available
Handling and StoragePrecautions for safe handling
Handling in a well ventilated place. Wear suitable protective clothing. Avoid contact with skin and eyes. Avoid formation of dust and aerosols. Use non-sparking tools. Prevent fire caused by electrostatic discharge steam.
Conditions for safe storage, including any incompatibilities
Store the container tightly closed in a dry, cool and well-ventilated place. Store apart from foodstuff containers or incompatible materials.
-
-
Seller Information
-
Business Type:
Trader
-
Main Products:
peptide
-
Location:
Hangzhou Peijia E-commerce Co., LTD
-
Year of Establishment:
2026
-
-
Inquiry History12 Inquiries
Country Product Purchase Quantity Date Posted
United States
Tripeptide-1
1 MT Jul 25, 2026
United Kingdom
Tirzepatide
2 PCS Mar 6, 2026
United States
Tripeptide
50 Dec 3, 2024
United States
Tripeptide
10 MG Jun 18, 2026
United States
Tripeptide
1 MG Jun 18, 2026
United States
Trizepatide
20 Jun 12, 2026
United States
Tripeptide
50 PCS Apr 18, 2026
United States
Tripeptide-1 CAS NO.72957-37-0
50 G Jul 28, 2026
United States
tirzepitide
20 MT Jul 8, 2026
United States
Epithalon
1 MG Jun 18, 2026
United States
Tripeptide
60 MG Jun 10, 2026
United States
Tripeptide
60 MG May 28, 2026 Post an enquiry for this product
